NAME | : | Belinostat |
BOBOT | : | 318.35 |
RUMUS | : | C15H14N2O4S |
THERAPEUTIC INDC | : | Belinostat is indicated for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL) with manageable safety profile.... |
CATEGORIES | : | Antineoplastic Agents / Histone Deacetylase Inhibitors |
STRUCTURE | : |